Polycystic ovarian syndrome (PCOS) is a highly variable syndrome and one of the most common female endocrine disorders. Although the association inositols-glucomannan may represent a good therapeutic strategy in the treatment of PCOS women with insulin resistance, the effect of inositols on the metabolomic profile of these women has not been described yet.
|Titolo:||Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study|
TROISI, JACOPO (Corresponding)
|Data di pubblicazione:||2019|
|Appare nelle tipologie:||1.1.1 Articolo su rivista con DOI|